1. Home
  2. LEGN vs XP Comparison

LEGN vs XP Comparison

Compare LEGN & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • XP
  • Stock Information
  • Founded
  • LEGN 2014
  • XP 2001
  • Country
  • LEGN United States
  • XP Cayman Islands
  • Employees
  • LEGN N/A
  • XP N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • XP Investment Bankers/Brokers/Service
  • Sector
  • LEGN Health Care
  • XP Finance
  • Exchange
  • LEGN Nasdaq
  • XP Nasdaq
  • Market Cap
  • LEGN 7.0B
  • XP 7.5B
  • IPO Year
  • LEGN 2020
  • XP 2019
  • Fundamental
  • Price
  • LEGN $27.78
  • XP $18.77
  • Analyst Decision
  • LEGN Strong Buy
  • XP Buy
  • Analyst Count
  • LEGN 13
  • XP 6
  • Target Price
  • LEGN $75.67
  • XP $20.83
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • XP 7.8M
  • Earning Date
  • LEGN 05-13-2025
  • XP 05-27-2025
  • Dividend Yield
  • LEGN N/A
  • XP 3.46%
  • EPS Growth
  • LEGN N/A
  • XP 14.90
  • EPS
  • LEGN N/A
  • XP 1.33
  • Revenue
  • LEGN $728,303,000.00
  • XP $2,627,582,667.00
  • Revenue This Year
  • LEGN $65.96
  • XP $19.66
  • Revenue Next Year
  • LEGN $52.55
  • XP $12.78
  • P/E Ratio
  • LEGN N/A
  • XP $13.97
  • Revenue Growth
  • LEGN 112.46
  • XP 14.10
  • 52 Week Low
  • LEGN $29.27
  • XP $10.82
  • 52 Week High
  • LEGN $60.87
  • XP $22.23
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.61
  • XP 76.27
  • Support Level
  • LEGN $30.25
  • XP $15.51
  • Resistance Level
  • LEGN $33.30
  • XP $19.10
  • Average True Range (ATR)
  • LEGN 1.78
  • XP 0.49
  • MACD
  • LEGN -0.57
  • XP 0.25
  • Stochastic Oscillator
  • LEGN 5.19
  • XP 90.93

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About XP XP Inc.

XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.

Share on Social Networks: